Physician profile
Saebom Kim
NPI 1861109555
$578.24
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $516 · 2024: $62.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $578.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $232.78 | 2023 | Xarelto |
| Merck Sharp & Dohme LLC | $117.67 | 2023 | Verquvo |
| Esperion Therapeutics, INC. | $75.43 | 2023 | Nexletol |
| Bard Peripheral Vascular, INC. | $65.88 | 2023-2024 | Venclose Maven Catheter |
| Novartis Pharmaceuticals Corporation | $33.24 | 2023-2024 | |
| Medicomp INC | $22.10 | 2023 | Telepatch Cardiac Monitor |
| Amgen INC. | $17.98 | 2024 | Repatha |
| Boston Scientific Corporation | $13.16 | 2023 | Varithena Administration Pack |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saebom Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.